|Articles|April 1, 2009

Monitoring Protein Modifications of the Biogeneric Protein Interferon-Phenomenex Application Note

Newsletter

Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.

Subscribe

Related Content

Non-Targeted Screening Strategies and Challenges to Identify PFAS in Complex Food Matrices

ByGaud Dervilly,Fabrice Monteau,Bruno Le Bizec ,Nicolas Macorps

June 8th 2026

LC-MS Links Gut Metabolites to Anxiety Therapy

ByJohn Chasse

June 8th 2026

HTC-19 Insights: Strategies To Improve Peak Integration Accuracy and Data Reliability

ByHans-Gerd Janssen,Alasdair Matheson

June 8th 2026

Mass Spectrometry Approaches for Investigating Alpha-Synuclein Structural Changes in Neurodegenerative Disease

ByJohn Chasse

June 8th 2026

The Gas Chromatographer’s Tool Kit

ByNicholas H. Snow

June 8th 2026

Monitoring Protein Modifications of the Biogeneric Protein Interferon-Phenomenex Application Note

Related Content

Non-Targeted Screening Strategies and Challenges to Identify PFAS in Complex Food Matrices

LC-MS Links Gut Metabolites to Anxiety Therapy

HTC-19 Insights: Strategies To Improve Peak Integration Accuracy and Data Reliability

Mass Spectrometry Approaches for Investigating Alpha-Synuclein Structural Changes in Neurodegenerative Disease

The Gas Chromatographer’s Tool Kit

Trending on LCGC International

ASMS 2026 Award Winners Highlight the Future of Mass Spectrometry

A Look at the Major Technical Themes of ASMS 2026

Mass Spectrometry Approaches for Investigating Alpha-Synuclein Structural Changes in Neurodegenerative Disease

LC-MS Links Gut Metabolites to Anxiety Therapy

HPLC 2026 Preview: Bo Zhang on Moving Towards Precision Design and Manufacture of Chromatographic Materials